| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |